EUCTR2012-002477-59-FI进行中（未招募）1 期
Constitutional Delay of Growth and Puberty: towards evidence-based treatment
Taneli Raivio, Helsingin yliopistollinen keskussairaala0 个研究点目标入组 50 人开始时间: 2012年11月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Clinical and biochemical criteria: Age 14 yrs or more, mean testicular volume >2.5 mL and <4mL, serum testosterone <5 nM and the adolescent wants medical intervention. No signs of chronic diseases accounting for the delayed puberty.
- •Biochemical criteria: As above, but serum testosterone >2 nM and normal serum DHEAS, even if the mean testicular volume is less than 2.5 ml.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 50
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Chronic diseases, primary hypogonadism, chromosomal anomalies, chronic medication that potentially adversely affects bone mineralization (excluding inhaled corticosteroid treatment).
研究者
相似试验
已完成
2 期
Constitutional Delay of Growth and Puberty: Towards Evidence-based TreatmentConstitutional Delay of Growth and PubertyNCT01797718Helsinki University Central Hospital35
已完成
4 期
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic DrugsNL-OMON34837Janssen-Cilag40
进行中（未招募）
不适用
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugsong-term safety data in children and adolescents will be collected from a population of patients with a diagnosis of schizophrenia, bipolar mania, autistic disorder or conduct and other disruptive disorders undergoing routine standard of care treatment.MedDRA version: 12.1Level: LLTClassification code 10039626Term: SchizophreniaMedDRA version: 12.1Level: HLGTClassification code 10026753Term: Manic and bipolar mood disorders and disturbancesMedDRA version: 12.1Level: LLTClassification code 10003805Term: AutismEUCTR2009-012003-26-GRJanssen-Cilag International, NV350
进行中（未招募）
1 期
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugsong-term safety data in children and adolescents will be collected from a population of patients with a diagnosis of schizophrenia, bipolar mania, autistic disorder or conduct and other disruptive disorders undergoing routine standard of care treatment.MedDRA version: 12.1Level: LLTClassification code 10039626Term: SchizophreniaMedDRA version: 12.1Level: HLGTClassification code 10026753Term: Manic and bipolar mood disorders and disturbancesMedDRA version: 12.1Level: LLTClassification code 10003805Term: AutismEUCTR2009-012003-26-BEJanssen-Cilag International, NV350
进行中（未招募）
不适用
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugsong-term safety data in children and adolescents will be collected from a population of patients with a diagnosis of schizophrenia, bipolar mania, autistic disorder or conduct and other disruptive disorders undergoing routine standard of care treatment.MedDRA version: 12.1Level: LLTClassification code 10039626Term: SchizophreniaMedDRA version: 12.1Level: HLGTClassification code 10026753Term: Manic and bipolar mood disorders and disturbancesMedDRA version: 12.1Level: LLTClassification code 10003805Term: AutismEUCTR2009-012003-26-NLJanssen-Cilag International, NV350